Ivan A. Letyagin
Ivan A. Letyagin has a total of 27 co-authors. Here are the top co-authors by number of shared publications:
- Nune V. Matinyan
N.N. Blokhin National Medical Research Centre of Oncology, Ministry of Health of Russia; N.I. Pirogov Russian National Research Medical University, Ministry of Health of Russia
5 shared publications - Ekaterina I. Belousova
N.N. Blokhin National Medical Research Centre of Oncology, Ministry of Health of Russia
3 shared publications - Leonid A. Martynov
Blokhin National Medical Research Center of Oncology, Moscow, Russia
3 shared publications - Tatyana L. Ushakova
N.N. Blokhin National Medical Research Centre of Oncology, Ministry of Health of Russia; Russian Medical Academy of Continuous Professional Education, Ministry of Health of Russia
3 shared publications - Vladimir G. Polyakov
N.N. Blokhin National Medical Research Center of Oncology of Ministry of Health of the Russian Federation
3 shared publications - Ekaterina A. Kovaleva
N.N. Blokhin National Medical Research Centre of Oncology, Ministry of Health of Russia
2 shared publications
Latest Publications
- 21 December 2024
- Published by ECO-Vector LLC in Regional Anesthesia and Acute Pain Management
- Vol. 18 (3) , 284-293
Experience of using multimodal opioid-saving anesthesia in children: single-center prospective randomized study
BACKGROUND: In the protocols of rapid recovery after surgery, it is recommended to avoid long-term administration and/ or high doses of opioids in order to reduce the severity of their adverse reactions in the postoperative period. In this regard, opioid-sparing anesthesia (OSA) may become a promising approach to the treatment of cancer patients. AIM: To evaluate the effectiveness of multimodal OSA in the scheme “dexmedetomidine + ketamine (in subanesthetic doses) + lidocaine (intravenous infusion)” in pediatric oncosurgery. MATERIALS AND METHODS: A single-center prospective randomized study involved 40 children aged 12 to 18 years. Patients were divided into 2 groups depending on the method of anesthesia: in group I (n =20), combined endotracheal anesthesia with opioids was performed, in group II (n =20) — multimodal OCA based on intravenous infusion of lidocaine, dexmedetomidine and subanesthetic doses of ketamine. The patients underwent extended operations in the head and neck area in the volume of thyroidectomy with fascial-sheath lymph dissection and excision of the central tissue of the neck from 2 sides. RESULTS: With stable intraoperative hemodynamic parameters, the median total intraoperative need for analgesics in group II was: for lidocaine — 351 (289.6; 418.5) mg (which is 1.75 mg/kg per hour), for dexmedetomidine — 88.2 (38.5; 119.7) µ g, for ketamine — 21.6 (17.4; 27.3) mg. In group I, the median total intraoperative need for fentanyl was 273.7 (406; 240.9) µ g. In addition, in group I, the median amount required for postoperative analgesia of the synthetic opioid analgesic tramadol was 419 (365.6; 479) mg (which is 7.8 mg/kg; p =0.01). In group II, the median amount of lidocaine required for postoperative analgesia (1 mg/kg per hour) turned out to be 1377.3 (735.7; 1894) mg, while additional tramadol administration at a dose of 57.3 (28.5; 107.7) mg was required in only 7 (35%) patients. CONCLUSION: Multimodal OSA based on dexmedetomidine, lidocaine, ketamine and sevoflurane is an effective and safe method of anesthesia in children from 12 to 18 years old, which is not inferior to opioid analgesics in the treatment of perioperative pain during surgical interventions on the thyroid and parathyroid glands in cancer patients, and also reduces the number of adverse reactions characteristic of opioids.
- 21 December 2024
- Published by ECO-Vector LLC in Regional Anesthesia and Acute Pain Management
- Vol. 18 (3) , 284-293
Experience of using multimodal opioid-saving anesthesia in children: single-center prospective randomized study
BACKGROUND: In the protocols of rapid recovery after surgery, it is recommended to avoid long-term administration and/ or high doses of opioids in order to reduce the severity of their adverse reactions in the postoperative period. In this regard, opioid-sparing anesthesia (OSA) may become a promising approach to the treatment of cancer patients. AIM: To evaluate the effectiveness of multimodal OSA in the scheme “dexmedetomidine + ketamine (in subanesthetic doses) + lidocaine (intravenous infusion)” in pediatric oncosurgery. MATERIALS AND METHODS: A single-center prospective randomized study involved 40 children aged 12 to 18 years. Patients were divided into 2 groups depending on the method of anesthesia: in group I (n =20), combined endotracheal anesthesia with opioids was performed, in group II (n =20) — multimodal OCA based on intravenous infusion of lidocaine, dexmedetomidine and subanesthetic doses of ketamine. The patients underwent extended operations in the head and neck area in the volume of thyroidectomy with fascial-sheath lymph dissection and excision of the central tissue of the neck from 2 sides. RESULTS: With stable intraoperative hemodynamic parameters, the median total intraoperative need for analgesics in group II was: for lidocaine — 351 (289.6; 418.5) mg (which is 1.75 mg/kg per hour), for dexmedetomidine — 88.2 (38.5; 119.7) µ g, for ketamine — 21.6 (17.4; 27.3) mg. In group I, the median total intraoperative need for fentanyl was 273.7 (406; 240.9) µ g. In addition, in group I, the median amount required for postoperative analgesia of the synthetic opioid analgesic tramadol was 419 (365.6; 479) mg (which is 7.8 mg/kg; p =0.01). In group II, the median amount of lidocaine required for postoperative analgesia (1 mg/kg per hour) turned out to be 1377.3 (735.7; 1894) mg, while additional tramadol administration at a dose of 57.3 (28.5; 107.7) mg was required in only 7 (35%) patients. CONCLUSION: Multimodal OSA based on dexmedetomidine, lidocaine, ketamine and sevoflurane is an effective and safe method of anesthesia in children from 12 to 18 years old, which is not inferior to opioid analgesics in the treatment of perioperative pain during surgical interventions on the thyroid and parathyroid glands in cancer patients, and also reduces the number of adverse reactions characteristic of opioids.
- Open Access
- 30 October 2024
- Published by OOO Grafika in Russian Journal of Pediatric Hematology and Oncology
- Vol. 11 (3) , 71-77
Anesthetic management in a patient with pheochromocytoma: a case report
Pheochromocytoma a tumor of the medullary layer of the adrenal gland composed of chromaffin cells that produces catecholamines (adrenaline, noradrenaline, and dopamine), is a special case of sympathetic paraganglioma.Pheochromocytoma is a life-threatening catecholamine-secreting tumor of chromaffin cells, which requires early and timely diagnosis and treatment. he clinical manifestations of pheochromocytoma are arterial hypertension, headaches predominantly in the occipital region, palpitations, tachycardia and hyperhidrosis.Anesthesiological support during surgeries for neoplasm removal (pheochromocytoma) is accompanied by life-threatening conditions in the perioperative period.Purpose to the study – to present the peculiarities of perioperative period management in a patient with pheochromocytoma.Materials and methods. A 17-year-old patient was diagnosed with pheochromocytoma of the right adrenal gland. After thorough preoperative preparation, surgical intervention in the volume of adrenalectomy was performed. Due to compliance with the modern strategy of anesthesiology adopted in our institution, the course of the postoperative period was stable. On the 3rd day after the operation the child was transferred to the specialized department, and on the 9th day he was discharged from the hospital under the dynamic observation of the endocrinologist at the place of residence. Event-free survival rate in the patient amounted to 82 weeks.Conclusion. Thorough preoperative preparation of the patient with alpha1-adrenoblockers for 1 month, stabilization of hemodynamics in the perioperative period prevents life-threatening complications, such as hemodynamic disorders in the form of intraoperative hypertension and subsequent hypotension after clamping of tumor-feeding vessels, postoperative hypotension, within the framework of combined anesthesia using epidural analgesia.
- 30 October 2024
- Published by OOO Grafika in Russian Journal of Pediatric Hematology and Oncology
- Vol. 11 (3) , 71-77
Open AccessAnesthetic management in a patient with pheochromocytoma: a case report
Pheochromocytoma a tumor of the medullary layer of the adrenal gland composed of chromaffin cells that produces catecholamines (adrenaline, noradrenaline, and dopamine), is a special case of sympathetic paraganglioma.Pheochromocytoma is a life-threatening catecholamine-secreting tumor of chromaffin cells, which requires early and timely diagnosis and treatment. he clinical manifestations of pheochromocytoma are arterial hypertension, headaches predominantly in the occipital region, palpitations, tachycardia and hyperhidrosis.Anesthesiological support during surgeries for neoplasm removal (pheochromocytoma) is accompanied by life-threatening conditions in the perioperative period.Purpose to the study – to present the peculiarities of perioperative period management in a patient with pheochromocytoma.Materials and methods. A 17-year-old patient was diagnosed with pheochromocytoma of the right adrenal gland. After thorough preoperative preparation, surgical intervention in the volume of adrenalectomy was performed. Due to compliance with the modern strategy of anesthesiology adopted in our institution, the course of the postoperative period was stable. On the 3rd day after the operation the child was transferred to the specialized department, and on the 9th day he was discharged from the hospital under the dynamic observation of the endocrinologist at the place of residence. Event-free survival rate in the patient amounted to 82 weeks.Conclusion. Thorough preoperative preparation of the patient with alpha1-adrenoblockers for 1 month, stabilization of hemodynamics in the perioperative period prevents life-threatening complications, such as hemodynamic disorders in the form of intraoperative hypertension and subsequent hypotension after clamping of tumor-feeding vessels, postoperative hypotension, within the framework of combined anesthesia using epidural analgesia.
- Open Access
- 3 September 2019
- Published by Practical Medicine Publishing House in Annals of Critical Care
- No. 3,p. 58-64
Efficacy and safety of retrobulbar blockade with ropivacaine during selective intraarterial chemotherapy in children with retinoblastoma. Article
Background. The goal of treatment of retinoblastoma is not only the preservation of life and vision, but also the minimization of systemic complications, a cosmetic defect, which is achieved through the development of selective intraarterial chemotherapy (SIACT). Repeated conduction of the SIACT at the time of catheterization a. ophtalmica is accompanied by cardio-respiratory disorders (CRD). Objectives. We analyze the effectiveness and safety of retrobulbar blockade with a 0.,5 % solution of ropivacaine to prevent or reduce CRD. Materials and methods. The study included patients from the Blokhin National Medical Research Center of Oncology with retinoblastoma under conditions of general anesthesia in 2017–2018 SIACT procedures were performed (n = 267). 83 patients were primary. 83 % of them had a mild and moderate degree of cardio-respiratory disorders during the second SIAHT procedure, 17 % of patients who were included in the study developed marked CRD (n = 14), for the prevention of which, during the third procedure of SIACT was performed retrobulbar blockade (RBB). Results. 4 (28.57 %) patients after retrobulbar blockade did not develop CRD in the third SIACT procedure, in 5 (35.7 %) patients after performing RBB, CRD symptoms decreased to moderate and in 5 (35.7 %) mild expressiveness. After the RBB, there was a lesser increase in airway resistance during inhalation of Pinsp 25.4 ± 7.4, versus 33.8 ± 3.2 with OA and more stable hemodynamics. When conducting retrobulbar blockade with a solution of ropivacaine 0.5 % with a volume of up to 1.5 ml, no complications were observed in children with retinoblastoma. Conclusion. In our experience, pronounced cardio-respiratory complications are often observed during repeated sessions of SIACТ in children with retinoblastoma and can be potentially life-threatening. Using of retrobulbar blockade with severe CRD may reduce the frequency and degree of development of respiratory disorders and is accompanied by greater hemodynamic stability.
- 3 September 2019
- Published by Practical Medicine Publishing House in Annals of Critical Care
- No. 3,p. 58-64
Open AccessEfficacy and safety of retrobulbar blockade with ropivacaine during selective intraarterial chemotherapy in children with retinoblastoma. Article
Background. The goal of treatment of retinoblastoma is not only the preservation of life and vision, but also the minimization of systemic complications, a cosmetic defect, which is achieved through the development of selective intraarterial chemotherapy (SIACT). Repeated conduction of the SIACT at the time of catheterization a. ophtalmica is accompanied by cardio-respiratory disorders (CRD). Objectives. We analyze the effectiveness and safety of retrobulbar blockade with a 0.,5 % solution of ropivacaine to prevent or reduce CRD. Materials and methods. The study included patients from the Blokhin National Medical Research Center of Oncology with retinoblastoma under conditions of general anesthesia in 2017–2018 SIACT procedures were performed (n = 267). 83 patients were primary. 83 % of them had a mild and moderate degree of cardio-respiratory disorders during the second SIAHT procedure, 17 % of patients who were included in the study developed marked CRD (n = 14), for the prevention of which, during the third procedure of SIACT was performed retrobulbar blockade (RBB). Results. 4 (28.57 %) patients after retrobulbar blockade did not develop CRD in the third SIACT procedure, in 5 (35.7 %) patients after performing RBB, CRD symptoms decreased to moderate and in 5 (35.7 %) mild expressiveness. After the RBB, there was a lesser increase in airway resistance during inhalation of Pinsp 25.4 ± 7.4, versus 33.8 ± 3.2 with OA and more stable hemodynamics. When conducting retrobulbar blockade with a solution of ropivacaine 0.5 % with a volume of up to 1.5 ml, no complications were observed in children with retinoblastoma. Conclusion. In our experience, pronounced cardio-respiratory complications are often observed during repeated sessions of SIACТ in children with retinoblastoma and can be potentially life-threatening. Using of retrobulbar blockade with severe CRD may reduce the frequency and degree of development of respiratory disorders and is accompanied by greater hemodynamic stability.
- Open Access
- 15 April 2019
- Published by Paediatrician Publishers LLC in Oncopediatrics
- Vol. 6 (1) , 25-33
Life-Threatening Complications During Superselective Ophthalmic Arterial Chemotherapy for Retinoblastoma: Retrospective Cohort Study
Background. Retinoblastoma is the most common intraocular malignant tumor in children. Substantial advances have been made in field of local treatment, in particular, through the development of selective intraarterial chemotherapy (SIAC). Life-threatening cardio-respiratory disorders were reported during the course of SIAC at the moment of a.ophthalmica catheterization. Objective. Our aim was to improve the safety and effectiveness of anesthetic management in children with retinoblastoma. Methods. The retrospective study included patients (n=203) who underwent SIAC (517) under general anesthesia in 2013–2018. Results. Hemodynamic parameters in patients who underwent SIAC procedure for the first time (211) were analyzed, in 186 (88%) cases, smooth anesthesia was observed, the deviations of blood pressure and heart rate did not exceed 20% of the baseline values. In 25 (12%) cases, patients who underwent the first SIAC procedure developed bronchospasm with a decrease in respiratory volume of up to 30% from the initial values 10–20 seconds after catheterization of a.ophthalmica with microcatheter. When analyzing hemodynamic parameters in patients who underwent repeated SIAC procedures (2nd, 3rd sessions, etc.) (306), in 177 (58%) cases, a clinical picture of the trigemino-pulmonary reflex of varying severity manifested. Conclusion. Severe cardio-respiratory complications are often observed during SIAC in children with retinoblastoma. These reactions occur predominantly during the second or subsequent procedures and can be potentially life-threatening. All patients with retinoblastoma who undergo SIAC should be considered at high risk.
- 15 April 2019
- Published by Paediatrician Publishers LLC in Oncopediatrics
- Vol. 6 (1) , 25-33
Open AccessLife-Threatening Complications During Superselective Ophthalmic Arterial Chemotherapy for Retinoblastoma: Retrospective Cohort Study
Background. Retinoblastoma is the most common intraocular malignant tumor in children. Substantial advances have been made in field of local treatment, in particular, through the development of selective intraarterial chemotherapy (SIAC). Life-threatening cardio-respiratory disorders were reported during the course of SIAC at the moment of a.ophthalmica catheterization. Objective. Our aim was to improve the safety and effectiveness of anesthetic management in children with retinoblastoma. Methods. The retrospective study included patients (n=203) who underwent SIAC (517) under general anesthesia in 2013–2018. Results. Hemodynamic parameters in patients who underwent SIAC procedure for the first time (211) were analyzed, in 186 (88%) cases, smooth anesthesia was observed, the deviations of blood pressure and heart rate did not exceed 20% of the baseline values. In 25 (12%) cases, patients who underwent the first SIAC procedure developed bronchospasm with a decrease in respiratory volume of up to 30% from the initial values 10–20 seconds after catheterization of a.ophthalmica with microcatheter. When analyzing hemodynamic parameters in patients who underwent repeated SIAC procedures (2nd, 3rd sessions, etc.) (306), in 177 (58%) cases, a clinical picture of the trigemino-pulmonary reflex of varying severity manifested. Conclusion. Severe cardio-respiratory complications are often observed during SIAC in children with retinoblastoma. These reactions occur predominantly during the second or subsequent procedures and can be potentially life-threatening. All patients with retinoblastoma who undergo SIAC should be considered at high risk.
- Open Access
- 20 April 2018
- Published by Paediatrician Publishers LLC in Oncopediatrics
- Vol. 5 (1) , 51-69
A New Era of Organ-Preserving Treatment in Pediatric Intraocular Retinoblastoma in Russia: A Multicenter Cohort Study
Background.Retinoblastoma (RB) is a life threatening cancer disease. A breakthrough in the treatment of children with RB is associated with the improvement of conservative treatment that was administered in at least one of the two tumor-affected eyes in most bilateral cases, that was chemotherapy both systemic and local (selective intra-arterial and intravitreal) in most cases combined with laser therapy, cryotherapy, or brachytherapy. The development of such techniques as local chemotherapy is focused on preservation of visual functions, reducing the number of enucleations and radiotherapy (RT) course. The success of the healing of RB is closely associated with a multidisciplinary approach to diagnosis and treatment, as well as specialized longterm follow-up clinical examination.Objective.eye and vision preservation against large intraocular tumors with different growth types and localization without the course of remote radiation therapy was the main purpose.Methods.In the period from September 2012 to January 2016, the study enrolled 45 patients with RB when at least one eye had intraocular tumor spread corresponding to the group C or D. According to the ABC international classification, patients have a relatively good prognosis for organ-preserving treatment. 4 of 18 children with bilateral RB had undergone primary enucleation of worse eye the worst eye, group E; 49 (77.8%) of the 63 affected eyes had features for groups C and D. In this study, no patient received local chemotherapy initially, only after prior systemic chemotherapy. Selective intra-arterial chemotherapy (SIAC) was applied to 41 patients (45 eyes; mean course number was 2), and 32 patients (34 eyes) had undergone intravitreal chemo therapy (IViC) (mean course number was 2). Focal therapy and local chemotherapy were the main methods of treatment for progression (new lesions on the retina) in 8 (16.3%) of 49 eyes with tumors of group C (n=1) and D (n=7); the relapse in 14 of 49 (new lesions on the retina) in eyes with tumors of group C (n=5) and D (n=6) and (new lesions on the retina and the vitreous) in eyes with tumors of group D (n=3) (28.5%), and stabilization of disease n=23 (46.9%). We should note that 2 patients underwent repeated course of in case of systemic chemotherapy, 1 patient — a Gamma Knife procedure due to registered disease stabilization, progression or relapse.Results.10 (20.4%) of 49 eyes saved due to the combined chemotherapy. In 45 patients diseasefree survival rate was 56.1±8.9 % (with mean follow-up period 26.9±2.5 months). 1 of 45 patients died from leukemia. 44 of 45 patients are alive without metastasis. The mean follow-up was 20 months (3 to 43 months). Eye salvage rate in group C — 14 (93.3%) of 15, in group D — 31 (91.2%) of 34.Conclusion.These methods: second line of systemic chemotherapy, RT, and a Gamma Knife procedure should be considered as a failure of primary treatment. Our study demonstrated a high efficacy of local chemotherapy with promissing techniques of conservation therapy, which safety increases due to experience.
- 20 April 2018
- Published by Paediatrician Publishers LLC in Oncopediatrics
- Vol. 5 (1) , 51-69
Open AccessA New Era of Organ-Preserving Treatment in Pediatric Intraocular Retinoblastoma in Russia: A Multicenter Cohort Study
Background.Retinoblastoma (RB) is a life threatening cancer disease. A breakthrough in the treatment of children with RB is associated with the improvement of conservative treatment that was administered in at least one of the two tumor-affected eyes in most bilateral cases, that was chemotherapy both systemic and local (selective intra-arterial and intravitreal) in most cases combined with laser therapy, cryotherapy, or brachytherapy. The development of such techniques as local chemotherapy is focused on preservation of visual functions, reducing the number of enucleations and radiotherapy (RT) course. The success of the healing of RB is closely associated with a multidisciplinary approach to diagnosis and treatment, as well as specialized longterm follow-up clinical examination.Objective.eye and vision preservation against large intraocular tumors with different growth types and localization without the course of remote radiation therapy was the main purpose.Methods.In the period from September 2012 to January 2016, the study enrolled 45 patients with RB when at least one eye had intraocular tumor spread corresponding to the group C or D. According to the ABC international classification, patients have a relatively good prognosis for organ-preserving treatment. 4 of 18 children with bilateral RB had undergone primary enucleation of worse eye the worst eye, group E; 49 (77.8%) of the 63 affected eyes had features for groups C and D. In this study, no patient received local chemotherapy initially, only after prior systemic chemotherapy. Selective intra-arterial chemotherapy (SIAC) was applied to 41 patients (45 eyes; mean course number was 2), and 32 patients (34 eyes) had undergone intravitreal chemo therapy (IViC) (mean course number was 2). Focal therapy and local chemotherapy were the main methods of treatment for progression (new lesions on the retina) in 8 (16.3%) of 49 eyes with tumors of group C (n=1) and D (n=7); the relapse in 14 of 49 (new lesions on the retina) in eyes with tumors of group C (n=5) and D (n=6) and (new lesions on the retina and the vitreous) in eyes with tumors of group D (n=3) (28.5%), and stabilization of disease n=23 (46.9%). We should note that 2 patients underwent repeated course of in case of systemic chemotherapy, 1 patient — a Gamma Knife procedure due to registered disease stabilization, progression or relapse.Results.10 (20.4%) of 49 eyes saved due to the combined chemotherapy. In 45 patients diseasefree survival rate was 56.1±8.9 % (with mean follow-up period 26.9±2.5 months). 1 of 45 patients died from leukemia. 44 of 45 patients are alive without metastasis. The mean follow-up was 20 months (3 to 43 months). Eye salvage rate in group C — 14 (93.3%) of 15, in group D — 31 (91.2%) of 34.Conclusion.These methods: second line of systemic chemotherapy, RT, and a Gamma Knife procedure should be considered as a failure of primary treatment. Our study demonstrated a high efficacy of local chemotherapy with promissing techniques of conservation therapy, which safety increases due to experience.